XML 78 R64.htm IDEA: XBRL DOCUMENT v3.5.0.2
RECEIVABLES (Details) - USD ($)
$ in Thousands
1 Months Ended 3 Months Ended 9 Months Ended
Jul. 31, 2015
Sep. 30, 2016
Sep. 30, 2016
Dec. 31, 2015
Accounts, Notes, Loans and Financing Receivable [Line Items]        
Accounts receivable, net of reserves   $ 14,955 $ 14,955 $ 12,458
Note receivable, current   46,526 46,526 46,849
Note receivable, long term   0 0 $ 45,573
Asklepion Pharmaceuticals, LLC | Asset Purchase Agreement        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
Proceeds from sale of asset $ 245,000      
Discount rate of future payments to be received 2.80%      
At Time Of Closing | Asset Purchase Agreement        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
Present value of future payments to be received $ 46,200      
At Time Of Closing | Asklepion Pharmaceuticals, LLC | Asset Purchase Agreement        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
Proceeds from sale of asset 150,000      
Due On First And Second Anniversaries Of Closing | Asset Purchase Agreement        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
Present value of future payments to be received 44,900      
Due On First And Second Anniversaries Of Closing | Asklepion Pharmaceuticals, LLC | Asset Purchase Agreement        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
Proceeds from sale of asset $ 47,500      
Interest expense | Asklepion Pharmaceuticals, LLC | Asset Purchase Agreement        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
Accretion on notes receivable   $ 300 $ 1,600